Skip to main content
. 2017 Sep 30;8(49):86710–86717. doi: 10.18632/oncotarget.21414

Table 3. Stratification analysis of MDM4 genotypes, OR, and 95% CIs by selected variables.

Variable HPV16+ patients (N =439) HPV16- patients (N =113) Adjusted OR (95%CI)*
No risk With 1-3 risk No risk With 1-3 risk No variants With variants
No. % No. % No. % No. %
All subjects 85 19.4 354 80.6 43 38.1 70 61.9 1.0 2.5 (1.6-3.9)
Age
 ≤54 years 50 22.2 175 77.8 18 30.5 41 69.5 1.0 1.6 (1.0-3.0)
 >54 years 35 16.4 179 83.6 25 46.3 29 53.7 1.0 1.9 (0.9-2.7)
Sex
 Male 75 19.5 309 80.5 32 37.6 53 62.4 1.0 2.8 (1.4-3.9)
 Female 10 18.2 45 81.8 11 39.3 17 60.7 1.0 3.1(1.1-9.2)
Ethnicity
 Non-Hispanic White 79 19.6 325 80.5 37 37.4 62 62.6 1.0 2.3 (1.4-3.8)
 Others 6 17.1 29 82.9 6 42.9 8 57.1 1.0 4.6 (0.9-21.7)
Smoking status
 Ever 51 20.2 201 79.8 29 38.7 46 61.3 1.0 1.6 (0.7-3.5)
 Never 34 18.2 153 81.8 13 35.1 24 64.9 1.0 2.3 (1.1-5.0)
Drinking status
 Ever 66 19.9 265 80.1 30 34.1 58 65.9 1.0 2.0 (0.9-4.0)
 Never 19 17.6 89 82.4 12 50.0 12 50.0 1.0 4.6 (1.8-12.2)

*Adjusted for age, sex, ethnicity, tobacco smoking and alcohol drinking status in a logistic regression model.

Reference group.